NEW YORK, Aug. 16, 2019 (GLOBE NEWSWIRE) --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Cambrex Corp. CBM
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cambrex Corp. CBM in relation to the proposed acquisition of the Company by private equity firm Permira Funds. Under the terms of the acquisition agreement, CBM shareholders will receive $60.00 in cash for each CBM share they own. If you own CBM shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/cambrex-corp/
Vitamin Shoppe, Inc. VSI
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Vitamin Shoppe, Inc. VSI in connection with the proposed acquisition of the Company by Liberty Tax, Inc. VSI shareholders will receive $6.50 for each share they own. If you own VSI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/vitamin-shoppe-inc/
Navigant Consulting, Inc. NCI
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Navigant Consulting, Inc. NCI in relation to the proposed acquisition of the Company by an affiliate of Veritas Capital. NCI shareholders will receive $28.00 in cash for each share they own. If you own NCI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/navigant-consulting-inc/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.